A double-blinded cross-over clinical trial investigating hemodynamic effects of exenatide on diabetic patients hospitalized for congestive heart failure.
Phase of Trial: Phase II
Latest Information Update: 24 Apr 2017
At a glance
- Drugs Exenatide (Primary)
- Indications Heart failure; Type 2 diabetes mellitus
- Focus Biomarker; Pharmacodynamics; Pharmacokinetics
- 13 Jan 2012 Results published in Diabetologia.
- 08 Aug 2011 New trial record